News and Publications

UPC_CFI_202/2024: CD Paris decides that subject-matter not complying with generally accepted laws of physics lacks industrial application according to Art. 57 EPC

Court docket: CD Paris, decision of 29.05.2025 - CFI 202/2024 [EP 3 655 346]Parties: 10x Genomics v. Curio Bioscience Inc. Contributor: Sebastian Rennebaum Headnote Article 57 ‘EPC’, according to...

UPC_CFI_359/2023, UPC_CFI_365/2023, UPC_CFI_702/2024: Mannheim grants first injunction for UK infringement; Paris confirms jurisdiction for Lugano state (Switzerland) infringement

(1) Court docket: LD Mannheim, decisions of 18 July 2025 – UPC_CFI_365/2023 [EP 3 511 174] and UPC_CFI_359/2023 [EP 3 476 616](1) Parties: FUJIFILM Corporation vs. Kodak GmbH/Kodak Graphic Communic...

G 1/23 - EPO no longer requires products to be enabled to form prior art

On July 2, 2025, the Enlarged Board of Appeal published the decision G 1/23 “Solar Cell”, in which HOFFMANN EITLE was heavily involved as representative of our long-standing client Mitsui Chemicals...

HOFFMANN EITLE congratulates newly qualified European Patent Attorneys

We are very proud to announce the HOFFMANN EITLE colleagues who have successfully qualified as a European Patent Attorney this year.Congratulations go to: Christina Courreges (Biotechnology, Munic...

UPC launches first phase of new Case Management System on 8 July 2025

The Unified Patent Court (UPC) will roll out the first phase of its new Case Management System (CMS) on Tuesday, 8 July 2025. To prepare for the launch, the current CMS will be unavailable from 3 J...

HOFFMANN EITLE recognized in IP STARS 2025 Rankings

We’re proud to announce that HOFFMANN EITLE has once again been recognized as one of Europe’s leading IP law firms in the 2025 IP STARS rankings by Managing IP: Tier 1 – Patent Prosecution (Patent...

UPC CFI 140/2024: LD Düsseldorf provides further guidance on claim interpretation in 10x Genomics vs. Curio Bioscience infringement decision

Court docket: LD Düsseldorf, decisions of 16.04.2025 - CFI 140/2024 [EP 2 697 391]Parties: 10x Genomics v. Curio Bioscience Inc. Contributor: Sebastian Giese Headnote As claim construction is a mat...

HOFFMANN EITLE recognized in Leaders League Rankings 2025

HOFFMANN EITLE has once again been recognized in the Leaders League 2025 rankings, earning distinctions across four key categories. The firm received the following ratings: "Leading" in th...

G 1/24 - The description always to be consulted for claim interpretation

In a landmark ruling on June 18, 2025, the Enlarged Board of Appeal of the European Patent Office issued its decision in referral G 1/24, settling a long-standing debate over how patent claims shou...

HOFFMANN EITLE Quarterly Newsletter 06/25

Dear Colleagues and Friends, In this issue of the Hoffmann Eitle Quarterly we begin with an analysis of the EU Commission’s long-awaited Teva decision, addressing the use - and alleged misuse - of...